Identification of KasA as the cellular target of an anti-tubercular scaffold

Katherine A. Abrahams(University of Birmingham), Robert H. Bates(Martha's Vineyard Hospital), Jonathan A. G. Cox(Aston University), Paul Homes(GlaxoSmithKline (United Kingdom)), Joël Lelièvre(South College), Gurdyal S. Besra(University of Birmingham), Nicholas J. Loman(University of Birmingham), Carolyn Selenski(GlaxoSmithKline (United Kingdom)), Elena Jiménez‐Navarro(GlaxoSmithKline (Spain)), Chun-wa Chung(GlaxoSmithKline (United Kingdom)), Íñigo Angulo‐Barturen(Euskadiko Parke Teknologikoa), Anthony Shillings(GlaxoSmithKline (United Kingdom)), N. Cammack(GlaxoSmithKline (Spain)), Lluís Ballell(GlaxoSmithKline (Spain)), Ruth Casanueva(GlaxoSmithKline (Spain)), Laurent Kremer(Inserm), Maria Santos Martínez(GlaxoSmithKline (Spain)), Marcus Bantscheff(Roche (Switzerland)), María José Rebollo-López(GlaxoSmithKline (Spain)), Mónica Cacho Izquierdo(GlaxoSmithKline (Spain)), Gerard Drewes(Unknown), Argyrides Argyrou(GlaxoSmithKline (United Kingdom)), Matthew Axtman(GlaxoSmithKline (United Kingdom)), Margarete Neu(GlaxoSmithKline (United Kingdom)), Sonja Ghidelli‐Disse(European Molecular Biology Organization), Sudagar S. Gurcha(Albert Einstein College of Medicine), David Barros(GlaxoSmithKline (Spain)), Alfonso Mendoza(GlaxoSmithKline (Spain)), Joaquín Rullás(GlaxoSmithKline (Spain)), Patrick J. Moynihan(University of Birmingham)
Nature Communications
September 1, 2016
Cited by 97


Related Papers